Ornipressin
| Names | |
|---|---|
| IUPAC name (2S)-N-[(2S)-5-Amino-1-[(2-amino-2-oxoethyl)amino]- 1-oxopentan-2-yl]-1-[(4R,7S,10S,13S,16S,19R)- 19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-16-[(4-hydroxyphenyl)methyl] -6,9,12,15,18-pentaoxo-13-(phenylmethyl)1,2-dithia-5,8,11,14,17- pentazacycloicosane-4-carbonyl]pyrrolidine-2-carboxamide | |
| Identifiers | |
| 3D model (JSmol) | |
| ChemSpider | |
| ECHA InfoCard | 100.020.231 | 
| MeSH | Ornipressin | 
| PubChem CID | |
| UNII | |
| CompTox Dashboard (EPA) | |
| 
 | |
| 
 | |
| Properties | |
| C45H63N13O12S2 | |
| Molar mass | 1042.19 g/mol | 
| Pharmacology | |
| H01BA05 (WHO) | |
| Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). Infobox references | |
Ornipressin is a vasoconstrictor, haemostatic and renal agent.